Aizentx
San Diego, US · 1 known investors
Aizen is an AI-native biotechnology company that designs novel oral peptides using non-canonical amino acids and an AI platform called DaX to treat chronic immune disorders. The company develops both proprietary therapeutics and partners with biopharma companies to advance gut-restricted and systemic oral biologics.
Founders & leadership
DV
David Van ValenFounder, Caltech Professor
AK
Ajay KshatriyaMBA
BG
Bernhard GeierstangerPhD
TP
Todd PetersonPhD